NCT03105115

Effect of Intrathecal Fentanyl on Spinal Anesthesia During Dexmedetomidine Infusion

Effect of Intrathecal Fentanyl on Spinal Anesthesia During Dexmedetomidine

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 56 (actual)
• Sponsor: Seoul National University Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

Intravenous infusion of dexmedetomidine during procedure was known to be associated prolonged duration of spinal anesthesia. In patients receiving dexmedetomidine infusion during procedure, it has been not evaluated whether use of adjuvant intrathecal fentanyl had additional prolonging effect on duration of spinal anesthesia or not. Therefore, the investigators planned this trial to compare clinical outcomes in patients receiving spinal anesthesia with heavy bupivacaine only and heavy bupivacaine plus fentanyl adjuvant.

Conditions

• Anesthesia, Spinal

Interventions

Type	Name	Description
DRUG	fentanyl	intrathecal fentanyl will be added as adjuvant for spinal anesthesia using heavy bupivacaine, while dexmedetomidine will be infused intravenously during operation
DRUG	bupivacaine only	heavy bupivacaine will be injected intrathecally during spinal anesthesia, without fentanyl, while dexmedetomidine will be infused intravenously during operation

Timeline

• Start date: 2017-05-25
• Primary completion: 2017-10-24
• Completion: 2017-10-26
• First posted: 2017-04-07
• Last updated: 2018-08-29

Locations

1 site across 1 country: South Korea